Target intelligence / Profile preview

Surface-adhesin protein E (PE)

Target
PE
Molecular classification
Bacterial surface protein, Lipoprotein, Adhesin, Outer membrane protein
01

Overview

Nontypeable Haemophilus influenzae Protein E (PE) is a highly conserved 16-kDa surface-exposed lipoprotein that functions as a multifunctional adhesin, critical for the colonization and persistence of the bacterium in the human respiratory tract [1, 11]. It facilitates bacterial adherence to host epithelial cells and extracellular matrix components, specifically laminin and vitronectin [13]. Beyond its role in adhesion, PE is a key factor in immune evasion, as it binds host complement regulators like C4b-binding protein (C4BP) and vitronectin to inhibit complement-mediated killing [3, 13]. It also interacts with host plasminogen, which may further promote bacterial pathogenesis and subvert innate immune responses [13]. Given its near-universal presence in clinical isolates and its essential role in virulence, PE is a primary target for the development of vaccines intended to prevent acute otitis media in children and exacerbations of chronic obstructive pulmonary disease (COPD) in adults [5, 8]. Current clinical efforts utilize PE or PE-fusion proteins (such as PE-PilA) combined with potent adjuvants to elicit protective, bactericidal, and adhesion-blocking antibodies [1, 2].

Other names
Protein EPEhpeompE16-kDa surface lipoproteinSurface-adhesin protein E
02

Mechanism of action

Induction of bactericidal antibodies, inhibition of bacterial adhesion to host cells, and blockade of bacterial complement evasion mechanisms

03

Biological functions

Cell adhesionImmune evasionComplement inhibitionBiofilm formationPlasminogen binding
04

Disease associations

InfectionChronic obstructive pulmonary disease (COPD)Otitis mediaPneumoniaSinusitis
05

Safety considerations

Injection site painFatigueReactogenicityPotential for immune escape due to haplotype diversity
06

Interacting drugs

NTHi-Mcat vaccine (GSK3277511A)

2 more in the full profile.

07

Biomarkers

Anti-PE IgG antibody concentrationAnti-PE IgA antibody concentrationPresence of Nontypeable Haemophilus influenzae in sputum

Beyond the preview

Go deeper on Surface-adhesin protein E (PE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Surface-adhesin protein E (PE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call